At the conclusion of this application-based activity, participants will be able to:
  • Evaluate the interrelationship between diabetes, glycemic control, and cardiovascular disease events..
  • Examine evidence from cardiovascular outcome trials (CVOT) of glucose lowering therapies and elucidate the proposed pleiotropic CV effects of these therapies in patients with diabetes.
  • Compare the data from real-world evidence studies of glucose lowering agents with the results of CVOTs, as well as potential implications for diabetes management strategies in patients with cardiovascular disease.
  • Explore opportunities for cardiologists, endocrinologists, primary care providers, and other members of the healthcare team to collaborate in order to improve diabetes management and reduce CV risk.